At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 18 enrolled
Drug / intervention
BLI-800drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
In Brief
A Phase 2 clinical trial evaluating BLI-800 for Colonoscopy and Bowel Preparation. Completed, enrolled 18 participants across 1 site.
Detailed Summary
To evaluate and compare the effects on safety measures and clinical chemistry after BLI800 in two groups of patients and one group of healthy controls. The patient groups will be those with mild or moderate hepatic impairment or moderate renal disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy, Bowel Preparation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedDec 2007
Primary CompletionApr 2008
Study CompletionJun 2008
TodayJul 2026
First PostedDec 31, 2007
Enrollment StartAug 1, 2007
Primary CompletionApr 1, 2008
Study CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.5 years ago
Interventions
BLI-800drug
BLI-800 oral solution (two doses)